Biosimilar switching in practice Hyrich: UK experience Switching to biosimilar has no immediate benefit to patients but
Tweet Content
Biosimilar switching in practice
Hyrich: UK experience
Switching to biosimilar has no immediate benefit to patients but saves NHS money
Allows for gain share that can be re-invested in pt care
Transparency in switching in explaining to pts and offering resource
@RheumNow #ACR24
Show on Archive Page
On
Display in Search Results
On
PDQ
Off